PhaseRx, Inc.
PZRXQ · OTC
12/31/2016 | 12/31/2015 | 12/31/2014 | |
|---|---|---|---|
| Market Cap | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 |
| % Growth | -100% | -68.8% | – |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 |
| % Margin | – | -1,439.2% | -414.2% |
| Net Income | -$0 | -$0 | -$0 |
| % Margin | – | -1,967.2% | -570.8% |
| EPS Diluted | -2.68 | -0.94 | -1.16 |
| % Growth | -185.1% | 19% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 |